Datasets:
tahasawan
/
Health_Dataset

Dataset card Data Studio Files
xet
 Community
2
Country
stringclasses
20 values
Year
int64
2k
2.02k
Disease Name
stringclasses
20 values
Disease Category
stringclasses
11 values
Prevalence Rate (%)
float64
0.1
20
Incidence Rate (%)
float64
0.1
15
Mortality Rate (%)
float64
0.1
10
Age Group
stringclasses
4 values
Gender
stringclasses
3 values
Population Affected
int64
1k
1,000k
Healthcare Access (%)
float64
50
100
Doctors per 1000
float64
0.5
5
Hospital Beds per 1000
float64
0.5
10
Treatment Type
stringclasses
4 values
Average Treatment Cost (USD)
int64
100
50k
Availability of Vaccines/Treatment
stringclasses
2 values
Recovery Rate (%)
float64
50
99
DALYs
int64
1
5k
Improvement in 5 Years (%)
float64
0
10
Per Capita Income (USD)
int64
502
100k
Education Index
float64
0.4
0.9
Urbanization Rate (%)
float64
20
90
Australia
2,014
Rabies
Viral
14.9
10.95
1.07
19-35
Male
779,698
81.52
1.33
6.51
Surgery
16,841
No
78.59
1,531
8.67
91,929
0.67
28.98
Brazil
2,024
Influenza
Metabolic
12.7
14.71
3.26
61+
Female
420,890
87.03
4.53
3.21
Surgery
650
No
57.46
4,406
0.15
93,797
0.59
35.18
South Korea
2,012
Asthma
Viral
14.35
12.46
4.56
0-18
Other
565,700
95.52
4.77
4.1
Medication
8,994
No
86.09
4,249
8.47
75,191
0.76
77.87
Saudi Arabia
2,008
Cholera
Metabolic
15.1
10.56
6.05
0-18
Other
608,299
77.09
4.2
2.1
Surgery
47,051
Yes
55.4
1,147
2.07
17,713
0.72
33.27
France
2,015
Malaria
Parasitic
15.58
8.6
4.73
36-60
Male
143,961
59.26
1.21
1.64
Medication
38,794
Yes
58.12
3,441
5.7
28,531
0.87
67.78
UK
2,009
Leprosy
Infectious
13.78
5.5
6.38
0-18
Female
391,975
92.09
1.37
2.63
Therapy
42,108
No
65.89
3,458
3.01
24,923
0.69
68.36
South Africa
2,001
Tuberculosis
Chronic
12.66
2.94
7.5
61+
Other
621,761
71.52
3.99
0.96
Vaccination
5,620
No
84.7
155
2.26
34,402
0.88
75.49
Japan
2,005
Cancer
Respiratory
2.32
14.54
7.25
19-35
Male
533,056
57.83
2.27
1.75
Therapy
5,069
No
87.52
1,982
5.89
11,763
0.87
83.67
Indonesia
2,005
Hepatitis
Autoimmune
19.53
5.57
2.2
0-18
Female
16,667
99.76
4.78
9.55
Surgery
36,443
No
60.7
2,678
8.86
75,756
0.83
67.27
Italy
2,023
Leprosy
Autoimmune
5.55
2.34
0.45
61+
Other
839,435
89.46
1.71
1.24
Medication
16,599
Yes
79.83
730
1.81
95,231
0.73
85.87
France
2,020
Dengue
Viral
16.02
1.29
5.72
61+
Male
593,749
92.79
0.62
2.06
Therapy
7,442
Yes
78.32
497
1.92
78,839
0.87
72.75
France
2,020
Rabies
Autoimmune
16.01
3.82
8.82
0-18
Female
514,095
54.77
3.58
9.37
Medication
44,988
Yes
78.24
277
5.5
67,938
0.77
37.47
Mexico
2,018
Leprosy
Chronic
12.29
4.67
2.55
36-60
Male
701,609
75.84
4.2
4.05
Vaccination
18,369
Yes
65.46
4,122
9.27
80,318
0.42
24.77
India
2,005
Dengue
Cardiovascular
12.72
5.54
8.98
0-18
Male
841,252
59.12
4.94
7.18
Therapy
8,696
Yes
52.18
2,122
4.74
99,781
0.82
83.83
Italy
2,018
Cholera
Infectious
14.31
0.94
3.7
61+
Female
500,654
52.07
1.91
7.48
Therapy
23,470
No
53.11
2,838
5.31
91,696
0.47
67.35
Indonesia
2,005
Cancer
Autoimmune
3.55
7.62
5.48
19-35
Female
109,920
57.34
0.92
5.65
Surgery
18,522
No
85.24
1,861
6.48
10,085
0.57
69.54
South Africa
2,007
Cancer
Neurological
9.31
7.1
5.38
61+
Male
51,730
73.36
4.47
8.09
Medication
23,158
No
74.71
3,732
9.04
93,907
0.63
30.93
South Korea
2,014
Cholera
Autoimmune
1.76
11.18
0.7
61+
Female
412,095
69.11
3.19
9.52
Vaccination
5,012
Yes
68.24
1,613
2.25
54,667
0.47
74.3
Russia
2,019
Rabies
Infectious
18.97
11.72
5.99
61+
Female
202,691
60.68
0.59
8.23
Vaccination
47,582
No
72.84
3,364
4.73
50,143
0.89
35.22
USA
2,002
Measles
Infectious
12.64
7.27
2.3
19-35
Male
985,408
82.77
4.57
6.59
Vaccination
18,334
Yes
88.13
3,842
8.55
5,638
0.71
68.38
Brazil
2,002
Influenza
Genetic
0.33
1.59
3.03
36-60
Female
162,586
52.88
4.79
8.19
Therapy
2,435
No
58.77
4,679
7.18
47,970
0.73
24.76
Nigeria
2,015
Leprosy
Neurological
3.75
13.05
5.04
61+
Female
272,219
94.03
0.55
0.95
Medication
31,391
Yes
83.56
3,270
5.63
24,069
0.63
65.24
Japan
2,007
Leprosy
Viral
1.52
0.25
1.72
36-60
Male
567,094
79.95
0.56
9.62
Medication
7,829
Yes
73.59
2,234
6.88
47,649
0.67
75.11
UK
2,017
Cancer
Bacterial
14.07
0.61
3.24
61+
Male
10,626
98.14
2.36
5.81
Medication
20,263
No
51.89
3,287
2.79
28,827
0.78
32.37
Argentina
2,014
Rabies
Viral
19.09
0.57
0.37
36-60
Other
487,857
99.76
1.93
7.93
Surgery
40,038
Yes
53.69
2,100
3.01
57,961
0.82
27.83
France
2,005
Dengue
Infectious
6.76
4.35
1.45
19-35
Other
505,838
79.11
2.6
3.32
Medication
40,149
No
53.63
2,075
3.55
1,134
0.68
24.99
Nigeria
2,020
Polio
Autoimmune
15.44
2.94
2.37
36-60
Other
261,271
72.75
4.04
3.93
Medication
9,703
Yes
98.22
382
3.02
36,514
0.67
84.01
India
2,013
COVID-19
Chronic
17.83
7.75
4.14
19-35
Male
110,130
50.73
4.94
9.99
Vaccination
11,797
No
65.75
2,227
0.06
69,383
0.45
89.19
Nigeria
2,010
Rabies
Genetic
9.6
3.85
7.27
36-60
Other
774,468
61.34
0.62
7.48
Therapy
39,575
No
86.13
1,370
4.53
27,429
0.46
85.19
Brazil
2,022
Zika
Respiratory
15.12
1.29
2.32
36-60
Male
731,934
81.72
1.89
1.99
Surgery
21,539
No
57.85
109
4.34
16,181
0.66
64.95
Saudi Arabia
2,004
Hepatitis
Bacterial
4.14
8.49
6.02
36-60
Female
744,110
99.8
2.53
7.04
Vaccination
46,495
No
51.97
1,444
2.72
72,898
0.69
80.94
Indonesia
2,009
Polio
Respiratory
16.43
14.59
4.59
0-18
Other
894,518
86
2.23
8.16
Vaccination
32,113
No
58.52
4,815
4.5
69,218
0.43
60.54
Germany
2,006
HIV/AIDS
Parasitic
16.32
12.84
7.18
19-35
Other
754,273
91.51
3.33
2.08
Therapy
47,338
No
84.41
3,635
4.1
79,302
0.47
56.89
Argentina
2,007
Parkinson's Disease
Infectious
13.8
3.95
7.11
36-60
Other
499,771
84.27
3.06
7.36
Vaccination
23,674
No
97.29
524
6.3
66,070
0.8
39.83
USA
2,008
Influenza
Cardiovascular
18.88
14.73
3.5
19-35
Male
126,959
93.29
1.44
6.75
Surgery
32,087
No
77.93
2,187
3.07
83,753
0.77
87.76
France
2,000
Hypertension
Chronic
13.46
10.75
3.63
36-60
Other
701,034
74.81
4.92
0.64
Therapy
32,675
Yes
87.97
2,492
6.63
99,126
0.81
31.05
Australia
2,007
Diabetes
Viral
18.12
14.87
6.94
61+
Male
206,224
90.7
4.77
3.94
Medication
49,958
No
59.3
3,190
9.08
39,737
0.52
54.75
Germany
2,017
Measles
Autoimmune
11.15
3.37
5.4
19-35
Female
733,866
93.63
1.62
5.08
Therapy
43,988
Yes
77.99
1,827
6.54
10,970
0.6
75.7
UK
2,001
Tuberculosis
Parasitic
15.9
4.89
5.49
0-18
Other
897,209
63.33
4.44
0.91
Medication
22,437
Yes
65.65
1,796
1.31
9,334
0.46
89.49
Germany
2,022
Hypertension
Infectious
8.42
3.03
4.21
19-35
Male
349,872
98.93
4.26
0.74
Medication
47,250
No
93.24
3,982
4.62
69,099
0.85
63.26
Italy
2,014
Leprosy
Respiratory
9.95
7.52
2.9
36-60
Male
136,925
88.35
0.71
4.91
Vaccination
45,226
Yes
75.68
3,295
6.75
76,524
0.72
82.66
Germany
2,021
HIV/AIDS
Infectious
7.74
1.8
6.51
61+
Female
795,754
56.35
1.42
4.68
Surgery
2,045
No
68.26
50
7.32
50,366
0.87
42.26
China
2,021
Measles
Neurological
17.63
11.06
3.9
19-35
Other
852,484
78.74
4.74
3.58
Vaccination
21,941
Yes
86.19
2,230
2.92
82,403
0.42
51.62
UK
2,016
HIV/AIDS
Respiratory
13.7
9.6
7.87
19-35
Other
619,413
83.04
2.3
6.35
Therapy
46,677
Yes
56.55
1,697
0.35
7,869
0.53
57.94
France
2,004
Ebola
Viral
16.62
13.76
0.45
36-60
Other
15,944
56.22
1.99
4.51
Surgery
37,593
Yes
66.05
3,774
9.16
9,333
0.71
42.69
Australia
2,020
Measles
Viral
3.7
13.41
8.15
36-60
Other
864,254
64.81
4.67
9.71
Surgery
41,831
Yes
96.23
3,587
5.41
42,023
0.64
20.11
Brazil
2,008
Cholera
Bacterial
2.6
13.64
1.11
36-60
Male
330,501
73.5
1.07
9.92
Vaccination
5,776
No
85.1
2,381
8.35
87,874
0.71
34.48
Canada
2,019
Zika
Parasitic
18.24
8.68
5.08
0-18
Male
980,768
51.32
1.25
8.94
Medication
31,824
Yes
53.6
4,217
9.28
38,020
0.59
43.67
USA
2,022
Parkinson's Disease
Cardiovascular
11.8
11.78
3.05
61+
Male
149,839
76.69
2.86
7.58
Vaccination
32,645
Yes
80.59
109
2.05
42,949
0.77
41.47
Indonesia
2,000
Parkinson's Disease
Metabolic
17.93
8.15
1.79
36-60
Male
614,307
61.1
2.71
6.42
Therapy
9,881
No
82.72
2,119
5.73
10,218
0.48
28.33
Germany
2,018
Hepatitis
Autoimmune
0.98
11.8
8.18
36-60
Male
25,715
95.5
1.89
5.33
Therapy
32,209
No
92.68
2,007
6.07
91,165
0.83
66.37
Russia
2,001
Rabies
Cardiovascular
9.57
6.51
3.91
61+
Other
191,852
79.3
3.01
7.27
Surgery
15,020
Yes
81.15
3,212
2.21
78,738
0.77
57.75
France
2,024
Influenza
Chronic
15.75
1.32
4.54
36-60
Female
490,010
75.11
4.83
5.81
Therapy
16,821
Yes
93.72
2,729
8.33
41,376
0.56
88.98
Canada
2,011
Ebola
Metabolic
14.6
0.19
7.13
36-60
Other
741,161
84.63
1.04
6.77
Therapy
7,978
No
52.88
2,439
5.36
27,408
0.71
79.29
Turkey
2,018
Cholera
Genetic
3.15
8.75
1.38
36-60
Other
323,467
98.09
2.86
1.43
Therapy
8,375
Yes
82.75
2,778
0.53
30,435
0.76
64.17
India
2,017
Parkinson's Disease
Genetic
4.91
9.52
4.57
0-18
Other
642,901
87.02
2.1
7.32
Vaccination
29,598
No
74.34
15
8.43
38,908
0.65
81.51
Mexico
2,009
Parkinson's Disease
Metabolic
2.05
3.93
5.94
36-60
Female
59,251
99.44
4.64
6.77
Vaccination
44,457
Yes
77.47
2,380
5.56
95,662
0.71
83.87
Turkey
2,022
Hypertension
Neurological
6.65
13.05
9.6
36-60
Male
509,170
71.69
1.85
9.29
Therapy
33,883
No
50.29
987
1.27
55,100
0.56
40.37
UK
2,004
Cholera
Respiratory
8.94
10.3
3.19
19-35
Female
922,492
87.84
1.43
6.07
Therapy
17,553
No
80.25
4,038
8.79
14,371
0.8
31.87
India
2,014
Cholera
Infectious
18.4
4.83
4.92
0-18
Other
776,951
84.73
3.34
4.04
Surgery
19,224
No
51.21
3,793
5.82
62,667
0.72
66.97
Brazil
2,000
Alzheimer's Disease
Infectious
5.62
3.38
4.21
19-35
Other
373,441
76.48
2.06
3.09
Vaccination
41,170
No
52.93
1,119
7.13
74,437
0.53
83.52
Argentina
2,000
Parkinson's Disease
Cardiovascular
4.86
13.77
6.56
36-60
Female
703,783
56.1
4.76
1.64
Vaccination
29,986
Yes
60.29
2,275
2.53
23,917
0.77
39.98
Turkey
2,014
Measles
Respiratory
18.82
11.65
1.9
19-35
Other
133,104
61.24
2.24
9.44
Vaccination
41,838
No
50.47
3,821
2.78
30,598
0.52
86.49
UK
2,011
Leprosy
Chronic
7.9
8.46
1.56
19-35
Male
269,159
95.04
3.38
8.11
Medication
35,868
Yes
75.41
323
2.68
45,484
0.8
80.88
Brazil
2,024
Influenza
Bacterial
11.3
13.26
6.13
19-35
Male
400,271
78.85
2.85
9.82
Surgery
20,403
Yes
68.94
604
7.94
44,015
0.76
50.82
Brazil
2,014
Alzheimer's Disease
Metabolic
13.06
14.9
3.85
36-60
Female
863,259
85.11
3.49
4.99
Therapy
22,556
Yes
77.45
4,786
9.95
72,367
0.76
40.13
Indonesia
2,010
Rabies
Bacterial
0.82
0.43
9.93
36-60
Male
703,894
95.4
3.07
6.81
Surgery
39,105
Yes
63.36
4,531
0.17
13,583
0.42
59.33
Australia
2,006
Polio
Bacterial
14.83
10.09
4.64
19-35
Female
883,662
95.89
3.17
7.8
Surgery
18,446
Yes
84.91
2,148
2.14
72,955
0.54
28.71
Canada
2,008
Asthma
Infectious
18.44
8.52
7.76
0-18
Other
144,702
50.24
3.36
6.46
Surgery
13,128
No
80.39
4,201
9.11
12,559
0.59
84.99
Saudi Arabia
2,023
Zika
Neurological
8.12
2.65
1.34
0-18
Female
413,700
68.27
2.9
9.69
Therapy
33,763
Yes
92.48
2,679
0.96
74,991
0.69
41.07
Canada
2,002
Rabies
Parasitic
11.43
13.06
4.59
36-60
Female
779,856
54.48
3.17
2.86
Therapy
48,344
No
83.65
4,791
0.71
95,005
0.68
38.63
Turkey
2,018
Diabetes
Viral
18.24
8.09
1.8
61+
Female
408,285
80.58
3.77
3.68
Vaccination
23,338
No
52.11
664
6.28
62,474
0.71
33.9
South Korea
2,021
Cancer
Respiratory
9.63
3.08
1.6
19-35
Male
934,854
99.02
2.88
3.76
Therapy
9,301
No
56.67
1,229
3.31
83,262
0.84
26.73
South Korea
2,003
Polio
Cardiovascular
14.37
12.02
2.6
61+
Female
780,191
73.67
2.76
6.35
Therapy
30,900
Yes
62.98
3,319
4.54
46,862
0.77
40.24
Italy
2,006
Tuberculosis
Metabolic
0.91
14.86
7.76
36-60
Male
896,608
78.15
1.75
1.48
Vaccination
17,117
Yes
74.81
873
6.79
78,129
0.69
29.45
Japan
2,000
HIV/AIDS
Cardiovascular
3.14
13.47
4.2
61+
Other
204,016
98.11
1.03
1.05
Surgery
11,538
No
59.38
313
5.68
88,191
0.58
78.9
South Africa
2,002
COVID-19
Viral
16.81
3.23
7.39
19-35
Female
470,955
93.98
1.41
3.88
Medication
34,806
No
77.65
1,411
3.24
67,605
0.44
39.44
Canada
2,012
Zika
Bacterial
8.61
2.73
2.26
36-60
Other
949,385
52.08
4.63
6.89
Medication
9,703
Yes
83.16
2,551
4.98
37,369
0.86
77.92
Indonesia
2,009
Dengue
Metabolic
6.44
8.44
0.86
19-35
Male
687,786
60.01
2.29
5.3
Vaccination
195
Yes
89.02
3,085
8.81
90,004
0.52
82.18
Italy
2,002
Malaria
Parasitic
9.87
1.95
3.9
0-18
Female
655,401
62.1
0.77
2.77
Surgery
17,711
Yes
90.58
3,950
2.9
96,428
0.74
48.66
South Africa
2,020
Ebola
Autoimmune
17.25
7.87
3.66
0-18
Other
148,785
56.23
4.15
9.34
Surgery
7,891
Yes
51.96
3,147
4.05
14,549
0.78
24.4
Indonesia
2,005
HIV/AIDS
Metabolic
14.14
5.89
9.02
36-60
Male
843,300
55
4.62
4.56
Therapy
1,073
Yes
97.49
2,547
9.58
2,179
0.67
36.64
Indonesia
2,021
Influenza
Autoimmune
2.48
2.57
2.03
0-18
Other
584,925
68.79
3.42
4.51
Medication
10,255
No
80.03
4,331
8.2
71,483
0.6
50.56
Germany
2,014
Parkinson's Disease
Genetic
2.15
8.94
4.58
0-18
Male
124,719
57.84
2.81
4.43
Medication
24,125
Yes
56.51
114
5.02
65,837
0.78
31.35
Germany
2,002
Hepatitis
Cardiovascular
7.13
7.71
7.74
36-60
Female
494,613
51.17
3.77
6.27
Medication
46,354
No
95.09
1,538
8.58
90,492
0.64
86.74
India
2,024
Leprosy
Infectious
16.01
4.69
8.69
19-35
Male
449,513
72.27
3.53
9.92
Therapy
39,467
No
63.14
3,568
6.34
83,270
0.66
48.21
South Africa
2,022
Asthma
Bacterial
19.97
2.34
0.32
19-35
Other
542,641
99.41
1.89
8.57
Medication
37,764
No
63.48
896
5.77
4,421
0.83
27.51
Canada
2,016
Cancer
Chronic
5.54
7.23
3.87
36-60
Male
677,602
57.52
0.74
2.07
Medication
28,139
Yes
83.67
362
8.06
42,662
0.55
73.78
Russia
2,017
Cholera
Respiratory
12.18
0.65
5.87
0-18
Female
760,533
88.99
4.43
9.9
Therapy
2,552
No
81.21
2,799
0.31
34,745
0.65
79.41
France
2,013
Asthma
Chronic
7.45
12.16
0.96
0-18
Male
47,328
52.44
0.67
6.49
Medication
36,446
No
93.76
4,507
9.29
62,059
0.75
72.84
Argentina
2,019
Polio
Genetic
1.29
9.2
4.44
61+
Other
614,812
68.07
3.04
3.83
Medication
29,674
Yes
68.39
686
3.8
86,672
0.8
35.91
Japan
2,005
Alzheimer's Disease
Parasitic
18.53
6.47
5.04
36-60
Male
799,027
70.03
1.16
7.86
Therapy
21,856
No
75.45
566
8.41
87,629
0.57
46.14
Argentina
2,005
Dengue
Neurological
5.57
5.16
0.88
19-35
Female
245,019
62.05
2.47
6.65
Surgery
21,333
No
81.7
2,930
8.55
97,062
0.8
58.01
Germany
2,005
COVID-19
Infectious
13.01
9.09
1.2
61+
Female
92,097
58.76
3.42
3.82
Surgery
33,297
Yes
65.26
3,473
7.14
57,702
0.51
37.02
Mexico
2,022
Hypertension
Neurological
10.89
13.71
4.62
0-18
Female
192,860
98.57
4.48
4.41
Vaccination
43,861
No
53.43
2,320
9.39
55,886
0.61
33.4
Japan
2,010
Rabies
Chronic
10.56
13.83
5.83
36-60
Female
864,603
86
2.56
7.25
Therapy
12,591
No
85.34
170
2.64
39,938
0.57
22.96
Germany
2,018
Cancer
Chronic
15.37
5.01
9.76
61+
Female
416,319
58.14
1.8
5.17
Therapy
42,332
Yes
84.96
1,831
1.34
96,500
0.56
85.54
Germany
2,016
Hypertension
Bacterial
10.67
3.67
5.85
61+
Other
799,004
60.71
2.47
3.48
Surgery
32,730
No
51.71
1,683
1.31
62,853
0.45
49.34
South Africa
2,010
Cholera
Parasitic
5.43
5.99
3.15
0-18
Female
247,824
75.19
3.43
6.97
Vaccination
22,930
No
62.16
4,634
7.74
80,728
0.43
53.29
Brazil
2,019
Tuberculosis
Autoimmune
15.65
2.55
7.44
0-18
Other
941,684
52.06
0.8
3.58
Surgery
19,989
No
89.08
213
0.4
49,684
0.59
75.48